PFIZER
Back to Cashflow Statement
|
PFIZER Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-798 Cr | ₹-205 Cr | ₹-235 Cr | ₹-346 Cr | ₹-181 Cr |
What is the latest Cash Flow from Financing Activities ratio of PFIZER ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-798 Cr |
| Mar2025 | ₹-205 Cr |
| Mar2024 | ₹-235 Cr |
| Mar2023 | ₹-346 Cr |
| Mar2022 | ₹-181 Cr |
How is Cash Flow from Financing Activities of PFIZER Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-798 Cr | Negative | |
| Mar2025 | ₹-205 Cr | Negative | |
| Mar2024 | ₹-235 Cr | Negative | |
| Mar2023 | ₹-346 Cr | Negative | |
| Mar2022 | ₹-181 Cr | - | |
Compare Cash Flow from Financing Activities of peers of PFIZER
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PFIZER | ₹17,398.9 Cr | -6.1% | -5.2% | -30.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,684.0 Cr | -1.4% | -6.5% | 5.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹241,311.0 Cr | -2% | -2.7% | 40.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,079.0 Cr | -1.8% | -7% | 29.6% | Stock Analytics | |
| CIPLA | ₹107,528.0 Cr | 0.1% | -3% | -15.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,667.0 Cr | 0.2% | 6% | -2.4% | Stock Analytics | |
PFIZER Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PFIZER | -6.1% |
-5.2% |
-30.9% |
| SENSEX | 2.7% |
-0.7% |
-10.5% |
You may also like the below Video Courses